A combination of Verzenio and letrozole has shown encouraging and lasting responses in patients with advanced or recurrent endometrial cancer, according to findings presented by Dr. Marilyn Huang, at ...
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of ...
Eisai Inc. today announced the presentation of findings from a new survey, which evaluated the experiences and perspectives of 119 U.S.-based patients who have been diagnosed with endometrial cancer ...
Current tests for endometrial cancer often rely on procedures like transvaginal ultrasound and tissue biopsy to evaluate the ...
Malignant diseases are the second leading cause of death in women. [1] With an incidence of 24 in 100,000, endometrial cancer is the fourth most common cancer in women. [2] When diagnosed at an early ...
—A study that explored trends in obesity and endometrial cancer in the U.S concluded that the combination of the 2 conditions hits younger women, and Black and Hispanic women in particular, the ...
—A new study from California-based researchers reports that things may be getting worse for certain women at risk for endometrial cancer. Here’s what the research team adds to what’s known about ...
In January, the American Cancer Society reported that for the first time women younger than 50 had a higher cancer incidence rate than men. Based on 2023 data, cancer incidence rates among women under ...
Taking at least 30 ibuprofen pills per month was associated with a significant reduction in the risk of endometrial cancer when compared to taking fewer than 4 pills per month. Frequent use of ...
Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results